mol42
22 Nov 2018
Oh 161118 Evening both yes this one Freddie [link] think you’ll find slides are as posted on our website [link] and not a lot different from those previously linked on thread (if at all - i haven’t compared in detail) bw Fred and omg mol mol
omg
22 Nov 2018
Oh 161118 Umm looks like he had a few sherbets the night before, we have all been there at exhibitions/conferences or just ill (that’s normally my excuse) omg
fhjhiscock
22 Nov 2018
Oh 161118 Thanks Mol…good to hear from you…Perhaps they have forgotten us. Or they might tell more at this evenings Edinburgh investor meeting. Can only hope! 65 staff…wow that’s a big bill…let’s hope they can generate a bit of revenue from Olav’s…‘gold dust’ Never know! Keep well. Best wishes. Freddie
mol42
20 Nov 2018
Oh 161118 slides ois.net CompanyShowcase_ReNeuron.pdf 2.52 MB mol
mol42
20 Nov 2018
Oh 161118 re hRPC didn’t think he was at his best mol
mol42
22 Oct 2018
Stem Cell Mesa 2018 MH presentation mol
omg
19 Oct 2018
Good news So the predictable slide. Don’t even get excited anymore omg
Prospero68
10 Oct 2018
Another drop Perhaps if he spent less time devising worthless share option schemes and started running the company instead…
stutes
10 Oct 2018
Another drop Aviva CEO was reportedly axed over share price, begs the question why haven’t Rene done the same?
mol42
03 Oct 2018
Board clear out well overdue? and of course never fully explained how 18 v 17 Other receivables 330 603 Prepayments and accrued income 955 457 Total trade and other receivables 1,285 1,060 we have that level of debtors - as we haven’t any sales i have noted before and still convinced we fund all grant work and await refund via grant awarded to our collaborators and us - ie they aren’t out any funds cashflow is all down to us - plc just an observation but our company should be more upfront re same - i have provided breakdown of grant awards previously and generally we are not main recipient - others fully funded but perhaps not out much in cashflow terms. mol
mol42
03 Oct 2018
Board clear out well overdue? still recruiting as of 1 oct [link] and reporting to head of analytics!! too much admin overhead (never mind those now reporting to mh - jees - as noted before the accounting function surely isn’t too overly complicated - no revenues for instance) and this in job description The role entails both lab-based activities and/or the on-site provision of technical leadership to third parties e.g. External GMP testing contract testing (sic) laboratories and external collaborators. therefore i presume no sign of licence in the near term! anyway the history of this company does tell a story - unfortunately i thought that was behind us several years ago - seems not mol
mol42
03 Oct 2018
Board clear out well overdue? I don’t necessarily agree re total clear out though agree re non execs not perhaps doing enough/performing in their duties up to shareholders as stutes has noted however at each agm to date all re-elected and will presumably continue to be and as i’ve noted share options granted to all! anyway emoluments 18 v 17 (k) jb 53 52 oh 413 401 mh 280 281 sc 38 38 tc 25 30 cd’a 21 - (recently appointed) ce 26 26 (c24m shares well underwater) pbh 20 34 (now gone) mo 26 26 Totals 902 888 the non execs emoluments not overly paid but jb as chair must take responsibilty re exec pay and grant of options - obviously he hasn’t to date - presumably because he believes their pay is not excessive and grant of options is reasonable - i don’t and nor do guidelines anyway we haven’t to date changed anything on this bb nor will we ever mol
fhjhiscock
03 Oct 2018
Board clear out well overdue? I’ll agree to that proposal…too many hangers on…
stutes
03 Oct 2018
Board clear out well overdue? The major shareholders need to show their backers that the investment in Rene, although below water, is safe - in my view that means an Ashley -style clear out of the directors who have not delivered the trials to programme.
